RA CAPITAL MANAGEMENT, L.P.: 13F holdings
CIK 13468242026Q2
| Positions | 84 |
|---|---|
| Reported value | $11.5bn |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| ASCENDIS PHARMA A/S | 10,281,496 | $2.7bn | 23.8% |
| PARABILIS MEDICINES INC | 28,933,371 | $791.9m | 6.9% |
| RYTM RHYTHM PHARMACEUTICALS INC | 6,666,837 | $740.2m | 6.4% |
| PCVX VAXCYTE INC | 11,474,599 | $667.0m | 5.8% |
| SIONNA THERAPEUTICS INC | 9,905,045 | $435.7m | 3.8% |
| TYRA BIOSCIENCES INC | 12,198,625 | $389.6m | 3.4% |
| EWTX EDGEWISE THERAPEUTICS INC | 8,392,730 | $341.0m | 3.0% |
| NEWAMSTERDAM PHARMA CO NV | 9,550,191 | $323.7m | 2.8% |
| HEMAB THERAPEUTICS HOLDINGS | 7,808,627 | $286.8m | 2.5% |
| SEPTERNA INC | 6,995,858 | $234.3m | 2.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1346824")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.